Search results
Dyne Therapeutics Inc (DYN) Stock: Evaluating the Annual Growth – News Heater
NewsHeater· 24 hours agoThe volatility ratio for the week is 6.38%, and the volatility levels for the last 30 days are 5.67% for Dyne Therapeutics Inc The simple moving average for the past 20 days is 31.73% for < ...
Why Is Dyne Therapeutics Stock Soaring On Monday?
Benzinga via Yahoo Finance· 9 hours agoMonday, Dyne Therapeutics Inc (NASDAQ:DYN) released clinical data from its ongoing Phase 1/2 ACHIEVE trial of DYNE-101 in patients with myotonic...
Dyne Therapeutics launches $300 million stock offering By Investing.com
Investing.com· 11 hours agoDyne Therapeutics, Inc. (NASDAQ:DYN), a clinical-stage company specializing in muscle disease...
Dyne Therapeutics Inc. stock jumps following trial updates
Investing.com· 1 day agoDyne Therapeutics Inc. stock jumps following trial updates
Oxana Beskrovnaya Sells 2,705 Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN) Stock
ETF DAILY NEWS· 2 days agoDyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) insider Oxana Beskrovnaya sold 2,705 shares of the stock in a transaction that occurred on Thursday, May 16th. Following ...
New York State Common Retirement Fund Grows Position in Dyne Therapeutics, Inc. (NASDAQ:DYN)
ETF DAILY NEWS· 4 days agoNew York State Common Retirement Fund raised its holdings in shares of Dyne Therapeutics, Inc. (NASDAQ:DYN – Free Report) by 13.7% during the fourth quarter, according to ...
Why This Biotech Just Launched — Again — After Its 166% Run
Investor's Business Daily· 11 hours agoDyne studied drugs it calls DYNE-101 and DYNE-251 in patients with myotonic dystrophy type 1 and...
Dyne therapeutics executive sells over $78k in stock By Investing.com
Investing.com· 3 days agoDyne Therapeutics, Inc. (NASDAQ:DYN) Chief Business Officer Jonathan McNeill has sold a portion of...
Dyne therapeutics CSO sells shares worth over $76k By Investing.com
Investing.com· 3 days agoDyne Therapeutics, Inc. (NASDAQ:DYN) reported a recent sale of shares by Chief Scientific Officer...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 2 days agoWALTHAM, Mass., May 19, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming ...
